Download interactions: TXT MITAB-2.5
| Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
|---|---|---|---|---|---|---|
|
PTPRK
Receptor-type tyrosine-protein phosphatase kappa |
3 |
13 |
High-throughput |
0.861 | High |
|
|
TSHR
Thyrotropin receptor |
3 |
8 |
High-throughput |
0.770 | High |
|
|
IL7RA
Interleukin-7 receptor subunit alpha |
1 |
0 |
High-throughput |
0.656 | High |
|
|
TPA
Tissue-type plasminogen activator |
1 |
15 |
Small-scale |
0.647 | High |
|
|
CD44
CD44 antigen |
2 |
5 |
High-throughput |
0.628 | High |
|
|
DEF1
Neutrophil defensin 1 |
2 |
5 |
High-throughput |
0.628 | High |
|
|
TAZ
Tafazzin |
3 |
1 |
High-throughput |
0.609 | High |
|
|
ISK4
Serine protease inhibitor Kazal-type 4 |
2 |
0 |
High-throughput |
0.602 | High |
|
|
SDC2
Syndecan-2 |
1 |
1 |
Small-scale |
0.578 | High |
|
|
SG2A2
Mammaglobin-A |
2 |
5 |
High-throughput |
0.574 | High |
|
|
GML
Glycosyl-phosphatidylinositol-anchored molecule-like protein |
2 |
3 |
High-throughput |
0.574 | High |
|
|
CFTR
Cystic fibrosis transmembrane conductance regulator |
2 |
4 |
High-throughput |
0.549 | High |
|
|
APC
Adenomatous polyposis coli protein |
1 |
4 |
High-throughput |
0.541 | High |
|
|
CST8
Cystatin-8 |
1 |
12 |
High-throughput |
0.536 | High |
|
|
CEAM8
Carcinoembryonic antigen-related cell adhesion molecule 8 |
1 |
14 |
High-throughput |
0.536 | High |
|
|
SLUR1
Secreted Ly-6/uPAR-related protein 1 |
1 |
9 |
High-throughput |
0.536 | High |
|
|
SLAF1
Signaling lymphocytic activation molecule |
1 |
14 |
High-throughput |
0.536 | High |
|
|
OS9
Protein OS-9 |
1 |
7 |
High-throughput |
0.536 | High |
|
|
IGFL3
Insulin growth factor-like family member 3 |
1 |
7 |
High-throughput |
0.536 | High |
|
|
CA054
Uncharacterized protein C1orf54 |
1 |
6 |
High-throughput |
0.536 | High |
|
|
LCFC1
Sperm-egg fusion protein LLCFC1 |
1 |
2 |
High-throughput |
0.536 | High |
|
|
C1QT7
Complement C1q tumor necrosis factor-related protein 7 |
1 |
15 |
High-throughput |
0.536 | High |
|
|
FBX2
F-box only protein 2 |
1 |
20 |
High-throughput |
0.536 | High |
|
|
HYOU1
Hypoxia up-regulated protein 1 |
1 |
2 |
High-throughput |
0.536 | High |
|
|
CXCL5
C-X-C motif chemokine 5 |
1 |
0 |
High-throughput |
0.513 | High |
|
|
SPCS3
Signal peptidase complex subunit 3 |
1 |
0 |
High-throughput |
0.513 | High |
|
|
DB125
Beta-defensin 125 |
1 |
0 |
High-throughput |
0.513 | High |
|
|
PLMN
Plasminogen |
1 |
13 |
Small-scale |
0.501 | High |
|
|
SG2A1
Mammaglobin-B |
1 |
5 |
High-throughput |
0.489 | High |
|
|
SG1D4
Secretoglobin family 1D member 4 |
1 |
2 |
High-throughput |
0.489 | High |
|
|
TAFA2
Chemokine-like protein TAFA-2 |
1 |
3 |
High-throughput |
0.489 | High |
|
|
TM87A
Transmembrane protein 87A |
1 |
2 |
High-throughput |
0.489 | High |
|
|
CAD23
Cadherin-23 |
1 |
4 |
High-throughput |
0.489 | High |
|
|
CST9L
Cystatin-9-like |
1 |
12 |
High-throughput |
0.489 | High |
|
|
ST14
Suppressor of tumorigenicity 14 protein |
1 |
9 |
High-throughput |
0.489 | High |
|
|
SDC1
Syndecan-1 |
1 |
2 |
Small-scale |
0.479 | High |
|
|
GPC1
Glypican-1 [Cleaved into: Secreted glypican-1] |
1 |
3 |
High-throughput |
0.479 | High |
|
|
CUL3
Cullin-3 |
1 |
15 |
High-throughput |
0.479 | High |
|
|
KDM3A
Lysine-specific demethylase 3A |
1 |
1 |
High-throughput |
0.470 | High |
|
|
RASH
GTPase HRas |
1 |
10 |
High-throughput |
0.445 | High |
|
|
S35E1
Solute carrier family 35 member E1 |
1 |
0 |
High-throughput |
0.438 | High |
|
|
TBG1
Tubulin gamma-1 chain |
1 |
4 |
High-throughput |
0.437 | High |
|
|
SOX2
Transcription factor SOX-2 |
1 |
2 |
High-throughput |
0.437 | High |
|
|
NUDC2
NudC domain-containing protein 2 |
1 |
3 |
High-throughput |
0.437 | High |
|
|
ANLN
Anillin |
1 |
5 |
High-throughput |
0.437 | High |
|
|
FBX6
F-box only protein 6 |
1 |
20 |
High-throughput |
0.437 | High |
|
|
SIR1
NAD-dependent protein deacetylase sirtuin-1 |
1 |
0 |
Small-scale |
0.269 | Low |
|
|
UCHL1
Ubiquitin carboxyl-terminal hydrolase isozyme L1 |
1 |
0 |
Small-scale |
0.249 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024
